Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 02/01/2019
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mark Albertini MD | Apeiron Biologics, Vienna, Austria Bristol Myers Squibb |
None | None | None | ✔ |
| Christopher Barker MD | Amgen Inc. Bristol Myers Squibb Elekta Merck & Co., Inc. University California San Francisco |
None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| William Carson III MD | None | None | None | None | ✔ |
| Daniel Coit MD, FACS | None | None | None | None | ✔ |
| Carlo Contreras MD | NA | NA | NA | NA | ✔ |
| Gregory Daniels MD, PhD | Bristol Myers Squibb Eisai Inc. Iovance Merck & Co., Inc. |
None | Array Biopharmaceuticals Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. |
None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | Decision Resources Group Consulting | None | None | - |
| Dominick DiMaio MD | None | None | None | None | - |
| Anita Engh PhD | None | None | None | None | - |
| Ryan Fields MD | None | None | None | None | ✔ |
| Martin Fleming MD, FACS | None | None | None | None | - |
| Morganna Freeman DO | NA | NA | NA | NA | ✔ |
| Anjela Galan MD | None | None | None | None | - |
| Brian Gastman MD | AbbVie, Inc. castle biosciences Merck & Co., Inc. quest imaging |
quest imaging | Castle Biosciences Merck & Co., Inc. |
None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Valerie Guild MBA | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Douglas Johnson MD, MSCI | None | Array Biopharma Bristol Myers Squibb Merck & Co., Inc. |
None | None | ✔ |
| Richard Joseph MD | None | Bristol Myers Squibb Merck & Co., Inc. |
None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Julie Lange MD, ScM | None | None | None | None | ✔ |
| Miguel Materin MD | None | Castle Bioscience Expert witness |
None | None | - |
| Nicole McMillian MS | None | None | None | None | - |
| Sameer Nath MD | None | None | None | None | ✔ |
| Anthony Olszanski MD, RPh | None | Array EMD Serono Iovance Merck & Co., Inc. Pfizer Inc. |
None | None | ✔ |
| Patrick Ott MD, PhD | None | Bristol Myers Squibb Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Aparna Priyanath Gupta MD | None | None | None | None | - |
| Kumar Rao MD | Castle Bioscience | None | None | None | - |
| Ramesh Rengan MD, PhD | None | None | None | None | - |
| Merrick Ross MD | None | Amgen Inc. CastleBiosciences Merck & Co., Inc. Novartis Pharmaceuticals Corporation Provectus Pharmaceuticals |
Amgen Inc. CastleBiosciences Merck & Co., Inc. Provectus Pharmaceuticals |
None | - |
| April Salama MD | Bristol Myers Squibb Celldex Therapeutics Dynavax Genentech, Inc. Immunocore Incyte Corporation Merck & Co., Inc. Reata Pharmaceuticals |
Array Biocryst Merck & Co., Inc. |
Bristol Myers Squibb | None | ✔ |
| Jack Skinner PhD | None | None | None | None | - |
| Joseph Skitzki MD | None | None | None | None | ✔ |
| Jeffrey Sosman MD | None | Array Pharma Bristol Myers Squibb Genentech, Inc. Incyte |
None | None | ✔ |
| Bettyanne Sunderland BSN, OCN | None | None | None | None | - |
| Susan Swetter MD | None | None | None | None | ✔ |
| Kenneth Tanabe MD | NIH/DCP Phase I clinical trial of oncolytic virus |
Advance Medical Best Doctors Department of Defense, CDMRP Helix12 LEK Consulting UpToDate |
None | None | - |
| John Thompson MD | Calithera Celldex Therapeutics |
AstraZeneca Pharmaceuticals LP Boehringer Ingelheim GmbH |
None | None | ✔ |
| Erin Vidic | None | None | None | None | - |
| Evan Wuthrick MD | None | None | None | None | - |